Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
9.06
-0.85 (-8.54%)
May 9, 2025, 1:15 PM - Market open

Theravance Biopharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
--56.42-55.19872.13-199.43-278.02
Upgrade
Depreciation & Amortization
-6.126.157.028.66.97
Upgrade
Loss (Gain) From Sale of Assets
-0.031.35-2.720.04-
Upgrade
Asset Writedown & Restructuring Costs
-4.51----
Upgrade
Loss (Gain) From Sale of Investments
--2.51-1.9---
Upgrade
Stock-Based Compensation
-21.3925.3739.7362.0662.98
Upgrade
Other Operating Activities
--5.035.56-960.95-67.5-16.9
Upgrade
Change in Accounts Receivable
--0.97-0.69-2.721.86.13
Upgrade
Change in Accounts Payable
-0.750.01-1.61-3.533.66
Upgrade
Change in Unearned Revenue
---0.22-0.19-11.46-26.47
Upgrade
Change in Income Taxes
-9.911.163.95-0.19-8.54
Upgrade
Change in Other Net Operating Assets
-10.67-8.54-17.08-26.17-12.56
Upgrade
Operating Cash Flow
--11.54-27-186.99-207.86-250.4
Upgrade
Capital Expenditures
--0.33-2.49-0.57-3.41-6.62
Upgrade
Sale of Property, Plant & Equipment
--1.514.580.010.06
Upgrade
Investment in Securities
-14.91-31.7254.87127.8917.27
Upgrade
Other Investing Activities
--2.29-1,095--
Upgrade
Investing Cash Flow
-12.28-32.71,154124.4910.72
Upgrade
Long-Term Debt Issued
-----380
Upgrade
Long-Term Debt Repaid
----631.6-10.73-235.35
Upgrade
Net Debt Issued (Repaid)
----631.6-10.73144.65
Upgrade
Issuance of Common Stock
-0.610.620.8111.65144.98
Upgrade
Repurchase of Common Stock
--3.1-199.55-132.28-9.06-9.75
Upgrade
Other Financing Activities
---4.28--16.8
Upgrade
Financing Cash Flow
--2.5-198.93-758.8191.86263.09
Upgrade
Net Cash Flow
--1.75-258.63208.218.523.4
Upgrade
Free Cash Flow
--11.87-29.49-187.56-211.26-257.02
Upgrade
Free Cash Flow Margin
--18.43%-51.35%-365.29%-381.96%-357.68%
Upgrade
Free Cash Flow Per Share
--0.24-0.53-2.55-3.04-4.12
Upgrade
Cash Interest Paid
---22.2439.0324.02
Upgrade
Cash Income Tax Paid
-0.110.02117.97-4.090.01
Upgrade
Levered Free Cash Flow
--42-12.2224-115.85-170.49
Upgrade
Unlevered Free Cash Flow
--40.41-10.7527.98-110.5-165.15
Upgrade
Change in Net Working Capital
-18.8141.076.25-31.2429.2342.46
Upgrade
Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q